CA
NZ
UK
AU
IND
US
Willow Health Services has voluntarily discontinued its advertising claims for compounded semaglutide products following a regulatory challenge. This development could reshape investor confidence in compounded medications, particularly as the market grapples with the implications of regulatory actions on weight loss solutions.[CTA: Join our daily …
Vir Biotechnology (NASDAQ: VIR) announced that CFO Jason O’Byrne will depart on Aug 3 and senior vice president Brent Sabatini will assume interim principal financial officer duties. The transition matters because investors will assess whether the interim leader can preserve financial reporting quality while …
UBS Group AG has reiterated its stock rating for Tenet Healthcare following strong second-quarter earnings, with reported EPS exceeding expectations. This affirmation comes as UBS shares have shown notable performance year-to-date, indicating investor confidence in the sector's potential for growth.[CTA: Join our daily market …
VivoSim Labs, Inc. reported stockholders’ equity of $(1.1 million), potentially risking its Nasdaq listing. The company has 45 calendar days to submit a compliance plan, impacting investor confidence significantly.[CTA: Join our daily market newsletter]Key HighlightsVivoSim Labs reported stockholders’ equity of $(1,099,000) as of March …
Gossamer Bio, Inc. (NASDAQ:GOSS) shares jumped sharply Monday after the company announced a series of regulatory, strategic and corporate updates that investors viewed as materially de-risking its path toward commercialization. The centerpiece of the announcement was confirmation that, following a Pre-NDA Type B meeting …
LENZ Therapeutics, Inc. (NASDAQ:LENZ) is the sort of small-cap that swings hard on modest news, and the gainers list recently showed the stock up roughly 9%. That specific move could not be tied to a single trading session or a fresh company disclosure, so …
MannKind Corporation (NASDAQ:MNKD) climbed roughly 6% on Friday, after the company said the U.S. Food and Drug Administration approved Furoscix ReadyFlow, an autoinjector that delivers subcutaneous furosemide in under 10 seconds for patients with fluid overload tied to heart failure or chronic kidney disease. …
MiNK Therapeutics (NASDAQ:INKT) screened this week among the day's percentage gainers, up roughly 7% on the reported figures. For a company this small, that number deserves a caveat before it deserves a headline. MiNK is a clinical-stage biotech with a single-digit-million-dollar cash balance and …
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) trades on the Nasdaq under the ticker ORIC and sits squarely in the highest-risk corner of the healthcare sector: clinical-stage oncology biotechnology. The company has no approved products and no product revenue. Its value rests entirely on a pipeline of …
Shares of Tenet Healthcare Corporation (NYSE:THC) surged roughly 17% on Friday, 24 July 2026, an unusually large single-day move for a large-cap hospital operator. The stock closed near $233, after touching an intraday high around $247, according to market reporting. The catalyst was clear …
Please wait processing your request...